Desire™ (Bremelanotide): A Neutral Review
Desire™ (Bremelanotide) :The only FDA-approved peptide for hypoactive sexual desire disorder (HSDD) in premenopausal women — backed by two Phase 3 trials showing statistically significant improvements in desire and distress, but with a 40% nausea rate, a blood pressure warning, a risk of permanent skin darkening, and a price tag that puts it out of…